相关实验视频

Updated: Jan 7, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

花花粉提取物与维生素在改善慢性前列腺炎患者的尿路和性功能方面的有效性:一项回顾性研究

Carlo Giulioni¹, Valentina Maurizi², Federico Falsetti³

¹Department of Urology, 47131 Casa di Cura Villa Igea , Ancona, Italy.

Journal of basic and clinical physiology and pharmacology

|December 25, 2025

概括

含有维生素的花花粉提取物 (PEV) 在患有慢性前列腺炎 (CP) 的男性中显著改善了泌尿和性功能. 与布洛芬相比,这种疗法在12个月内证明了持续的疗效和安全性.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
综合医学是一个整体的医学.
药理学药理学是指药理学的学科.

背景情况:

慢性前列腺炎 (CP) 显著影响男性的生活质量,影响尿路和性功能.
目前对CP的治疗有局限性,需要探索替代治疗方案.

研究的目的:

评估花花粉提取物与维生素 (PEV) 的有效性和安全性,以改善诊断为CP的男性的尿路和性功能.
为了在受控研究环境中比较PEV与布洛芬的效果.

主要方法:

一项追溯对照研究涉及145名患有脑膜炎的男性,分为PEV (n=71) 和易布洛芬 (n=74) 组.
临床和功能结果,包括IPSS,NIH-CPSI和IIEF-5得分,在基线和治疗后1,3个月和12个月被评估.

主要成果:

与布洛芬组相比,PEV组在3个月和12个月后在IPSS,NIH-CPSI和IIEF-5分数中显示出显著更大的改善.
在PEV组的这些功能性改善在12个月的研究期间持续并增强.
两组之间没有观察到Qmax的显著差异.

结论:

长期PEV治疗有效地显著改善了CP的男性的尿路和性功能.
与布洛芬相比,PEV在治疗脑脊髓炎症状方面表现出持续的,时间依赖的疗效和出色的安全性.

关键词:

慢性前列腺炎慢性前列腺炎这是勃起功能障碍.花花粉提取物花花粉提取物下泌尿道的症状下泌尿道的症状植物疗法是一种植物疗法.

更多相关视频

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Published on: January 16, 2013

相关概念视频

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...